DOTmed December 15, 2023
John R. Fischer

While clinical guidance in many countries, including the U.S., U.K., and EU, recommends performing coronary CT angiography (CCTA) before other, more invasive procedures to diagnose coronary artery disease, interoperability challenges cause its use to vary among providers worldwide. Philips and its academic and nonacademic partners are seeking to change this with a recently awarded €6.5 million (over $7 million) grant to the company’s public-private consortium, COMBINE-CT.

Earlier this month, the Innovative Health Initiative, an EU public-private partnership that funds health research and innovation, awarded the grant to the Philips consortium to support five multicenter clinical trials for determining and sharing best care practices around the use of CCTA in CAD diagnosis and treatment with providers worldwide, to create a more...

Today's Sponsors

Venturous
Got healthcare questions? Just ask Transcarent

Today's Sponsor

Venturous

 
Topics: Clinical Trials, Medical Devices, Patient / Consumer, Provider, Trends
What tariffs mean for the medical device industry - and who will pay for them?
FDA Debuts a New Communications and Compliance Tool for Device Data Integrity Concerns
Labcorp to buy Opko unit’s cancer test assets for up to $225M
Qualcomm CEO: AI Is the New User Interface for Devices
FTC sues to block merger of device coatings companies

Share This Article